Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
Pantoprazole 40 mg powder for solution for injection.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection. White to almost white powder. |
Each vial contains 40mg of pantoprazole (as sodium sesquihydrate).
| Active Ingredient | Description | |
|---|---|---|
| Pantoprazole |
Pantoprazole is a substituted benzimidazole which inhibits the secretion of hydrochloric acid in the stomach by specific blockade of the proton pumps of the parietal cells. |
| List of Excipients |
|---|
|
None. |
10 ml type-I tubular colourless glass vial with grey bromobutyl rubber stopper, sealed with a red flip-off tear-off aluminium seal.
Pantoprazole 40 mg powder for solution for injection is supplied in packs containing 1, 5, 10 or 50 vials.
Not all pack sizes may be marketed.
Sun Pharmaceutical Industries Europe B.V., Polarisavenue 87, 2132 JH Hoofddorp, The Netherlands
PL 31750/0011
01/07/2015
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
